4.4 Article

Change in intraindividual ICHD-II headache diagnosis over time: A follow-up of the DMKG headache study

期刊

CEPHALALGIA
卷 33, 期 1, 页码 25-33

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/0333102412465203

关键词

ICDH-II; migraine; tension-type headache; probable subtypes; diagnosis; intraindividual variability

资金

  1. German Migraine and Headache Society (DMKG)
  2. Almirall
  3. Astra Zeneca
  4. Berlin Chemie
  5. Boehringer
  6. Boots Health Care
  7. Glaxo-Smith-Kline
  8. Janssen Cilag
  9. McNeil Pharma
  10. MSD Sharp Dohme
  11. Pfizer
  12. German Science foundation
  13. German Minister of Research and Education
  14. Kroner-Fresenius foundation
  15. Addex
  16. Allergan
  17. Colucid
  18. GSK
  19. Ipsen
  20. Merz
  21. MSD
  22. Eisai
  23. UCB
  24. German Migraine and Headache Society
  25. Boehringer Ingelheim Pharma
  26. Boots Healthcare
  27. GlaxoSmithKline
  28. McNeil Pharmaceuticals

向作者/读者索取更多资源

Background: Change in headache diagnoses over time within the same individual is not well studied in the adult population. In this study, we prospectively examined the individual variation of migraine and tension-type headache (TTH) diagnoses over time. Methods: As part of the epidemiological Deutsche Migrane und Kopfschmerzgesellschaft (DMKG) headache study, 1312 participants were personally interviewed and 1122 responded to a second mailed questionnaire 2.2 years later. Headaches were assigned to migraine or TTH at two different points in time using the International Headache Classification, ICHD-II. We used broad (definite and probable subtypes) and strict (only definite type) definitions of migraine and TTH. Results: Using the broad definition increased the reproducibility of migraine diagnosis from 48.0% to 62.0% and of TTH from 59.0% to 65.0%. A constant TTH diagnosis was related to a higher social status (OR 2.81; 95% CI 1.43-5.53) a higher level of education (OR 1.96; 95% CI 1.00-3.85) and physical inactivity (OR 2.28; 95% CI 1.16-4.49). A constant diagnosis of definite migraine was associated with severe headache (OR 2.64; 95% CI 0.97-7.21) and frequent use of headache medication (OR 4.73; 95% CI 0.95-23.60). The result that coexisting TTH decreased the likelihood of a constant migraine (OR 0.29; 95% CI 0.10-0.85) is assumed to indicate response variability. Conclusions: In epidemiological studies, definite and probable subtypes should be included in the diagnosis to increase the diagnostic accuracy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据